VIVA and The VEINS 2025 will spotlight a dynamic series of Late-Breaking Clinical Trial presentations, showcasing cutting-edge research and pivotal data for vascular specialists. These sessions provide early insights into major randomized trials, long-term registry results, and first-in-human experiences with innovative devices and therapies.
Each presentation will be followed by an interactive discussion and audience Q&A, led by a panel of renowned experts. Don’t miss your chance to contribute to the conversation driving the next era of vascular innovation.
The 2025 abstract submission portal will open June 12 at 12pm PT.
VIVA and The VEINS embargo Late-Breaking Clinical Trial information from becoming public until after the commencement of the session as listed in the conference program or on viva-foundation.org. No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented.
Abstracts will be evaluated and scored based on the following criteria:
Submission Deadline: August 7
The review committee may determine that your abstract may be more appropriate for a different session or conference than you originally submitted.
If you have questions please contact Brita Thorne via e-mail: abstracts@viva-foundation.org
